By Karen Freifeld (Reuters) – A congressional committee focused on China has introduced a bill that would restrict federally funded medical providers from allowing China’s BGI Group, WuXi Apptec and other biotech companies from getting genetic information about Americans. The House select committee on China, led by Republican congressman Mike Gallagher, said the legislation unveiled on Thursday is aimed at BGI Group and its subsidiaries MGI and Complete Genomics, along with WuXi Apptec, according to a statement. Shares of Wuxi Apptec fell 10% in trading in China following news of the bill over…